drugset / Trial / NCT03633175

Progesterone in Patients With Placenta Previa

NCT03633175

Phase 2 Unknown 74 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelPrevention

Summary

This study evaluates the efficacy of prophylactic vaginal progesterone administration in reducing of the episodes of antepartum hemorrhage and subsequent prevention of preterm delivery in women with placenta previa.

Timeline

Start
2018-07-05
Primary completion
2019-07
Completion
2019-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 400 mg Other

Indications